Having successfully established domestic operations, the company ventured into international markets in the mid 90’s. 

Exports to Middle East, Africa & Asia Pacific:

  • Afghanistan 
  • Burundi
  • Iraq
  • Jordan
  • Mauritius
  • Kenya
  • Philippine
  • Sudan
  • Uganda
  • Tanzania
  • Srilanka

We are also at various stages of registration in:

  • Azerbaijan
  • Botswana
  • Cambodia
  • Libya
  • Nigeria
  • Senegal
  • Turkmenistan
  • Malaysia

Medipak is pre-qualified/certified by the World Health Organization in 1997 Medipak was approved by United Nations to supply Iraq, IV solutions under the “Food for Oil” program and has continued to do so.

With our globalization drive, we anticipate export to become a major growth driver in the coming years. In recognition of our outstanding performance  PESA – Pharma Exports Summit & Awards in nontraditional pharma exports, Medipak has been awarded the federation of Pakistan Chambers of Commerce & Industry’s “Merit Export Trophy” for the year 2002-2003, 2004-2005 and 2021-2022

Mr. Naveed K. Chowdhry – Chief Operating Officer & Ms. Naureen Khalid – Managing Director received PESA – Pharma Export Summit & Awards for Year 2020-2021 from Advisor to the PM on Commerce & Industry Mr. Abdul Razak Dawood in recognition for out standing export performance in non traditional pharmaceutical products.

Dr. Khalid J. Chowdhry – Chairman & Mr. Nasir J. Chowdhry – Managing Director receiving Merit Export Trophy Year 2002-2003 from President of Pakistan General Pervez Musharaf in recognition for out standing export performance in non traditional pharmaceutical products.

Mr. Nasir J. Chowdhry –  Managing Director & Mr. Naveed Khalid Chowdhry – Director receiving Merit Export Trophy Year 2004-2005 from President of Pakistan General Pervez Musharaf in recognition for out standing export performance in non traditional pharmaceutical products.


                                                                                                       Pakistan’s First Ever Pharma Export Awards                                       

Pakistan Pharmaceutical Manufacturer’s Association (PPMA) held it’s first-ever “Pharma Export Summit and Awards 2021” (PESA) on the 29th of September at Serena                                                                                                                           Hotel in Islamabad.

This event, first of its kind, was attended and addressed by Advisor to the Prime Minister on Commerce and Industry Abdul Razak Dawood, Federal Minister for Planning, Development and Special Initiatives Asad Umar and Special Assistant to PM (SAPM) on Health Dr. Faisal Sultan. Newly appointed SAPM on CPEC Khalid Mansoor who is tipped to become Chairman CPEC Authority was also attended amongst many other key officials from the federal government, DRAP Authorities & leading industrialist were amongst other key officials. Top Pharma performing companies like Getz, Herbion, Martin Dow, Hilton, Pharmevo, Genix, Sami, CCL, Medipak, Ferozsons, to name few were present to receive awards.

Pakistan’s pharmaceutical sector has assumed great importance for the Imran Khan government. Ministry of Commerce under Adviser to PM, Razzaq Dawood, has been trying to shape a four point agenda for country’s exports, defined as: Product Diversification, Regional Connectivity, Market Access and Look Africa. Pharma provides the much-needed product differentiation to Pakistani exports; it can provide market access in newly opening regions like Central Asia and Africa. In recent months Pharma exporters have travelled to Uzbekistan and Tajikistan along with the PM Imran Khan looking for opportunities to export and joint ventures for manufacturing. The worth of the pharmaceutical sector was estimated to be around $3.2 billion in 2020. Pakistan’s pharmaceutical exports went up by 23% to $68.1 million during the first quarter of the current fiscal year of 2020/21. 

Imran Khan Government has been taking number of initiatives to expand public health sector. Pakistan is the 5th most populous country with an estimated population of around 250 million and the value of pharmaceuticals manufactured in Pakistan has the potential to rise up to $5 billion by 2024-25. Given policy support by the government, the pharmaceutical industry has the potential to compete at the global level, while working in coherence with the government and regulatory agencies. First PESA event thus aims to highlight the triumphs of this sector and outline the potential to which it can contribute to the economy of Pakistan – given proper policy direction and facilitation by the government.